Uncategorized

Global Ocular Inflammation Treatment Market 2019-2023 | Strong Drug Pipeline to Boost Demand | Technavio

by Business Wire • 2018/12/03 • 0 Comments

LONDON--(BUSINESS WIRE)--#AbbVie--Technavio analysts forecast the global ocular inflammation treatment market to grow at a CAGR of more than 6% by 2023.

Full Story →

← FDA approves Dextenza for treatment of postoperative ocular pain

EZbra Breast Dressing to Make Post-Op Recovery Easier, Safer →

Post navigation